Elevance Health, Inc. $ELV Stock Sold by Western Wealth Management LLC

Western Wealth Management LLC cut its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 76.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 884 shares of the company’s stock after selling 2,902 shares during the period. Western Wealth Management LLC’s holdings in Elevance Health were worth $344,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Activest Wealth Management boosted its position in shares of Elevance Health by 146.2% in the third quarter. Activest Wealth Management now owns 64 shares of the company’s stock worth $25,000 after buying an additional 38 shares during the period. Kilter Group LLC purchased a new position in shares of Elevance Health during the 2nd quarter valued at $28,000. Elevation Wealth Partners LLC boosted its position in Elevance Health by 600.0% during the second quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock valued at $41,000 after purchasing an additional 90 shares during the last quarter. Tacita Capital Inc acquired a new stake in shares of Elevance Health during the 2nd quarter valued at about $44,000. Finally, Danske Bank A S acquired a new stake in Elevance Health in the second quarter valued at approximately $44,000. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Elevance Health Stock Down 2.5%

NYSE ELV opened at $390.88 on Friday. The stock has a fifty day moving average of $416.40 and a 200-day moving average of $376.69. The stock has a market capitalization of $84.45 billion, a P/E ratio of 16.67, a price-to-earnings-growth ratio of 1.91 and a beta of 0.63. Elevance Health, Inc. has a 52 week low of $274.84 and a 52 week high of $450.69. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.47 and a current ratio of 1.47.

Elevance Health (NYSE:ELV – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The company reported $6.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.71 by $2.28. Elevance Health had a return on equity of 14.97% and a net margin of 2.55%. The business had revenue of $50.44 billion for the quarter, compared to analyst estimates of $49.28 billion. During the same quarter in the prior year, the firm posted $6.03 earnings per share. The firm’s revenue for the quarter was up .7% compared to the same quarter last year. On average, equities research analysts forecast that Elevance Health, Inc. will post 29.16 EPS for the current year.

Elevance Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Stockholders of record on Friday, December 4th will be paid a $1.72 dividend. The ex-dividend date of this dividend is Friday, December 4th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.8%. Elevance Health’s dividend payout ratio is 29.34%.

Insider Transactions at Elevance Health

In other news, CFO Mark Kaye sold 10,584 shares of Elevance Health stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $440.13, for a total transaction of $4,658,335.92. Following the transaction, the chief financial officer directly owned 19,919 shares of the company’s stock, valued at $8,766,949.47. This trade represents a 34.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Ratnakar Lavu sold 1,300 shares of the business’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $440.00, for a total value of $572,000.00. Following the completion of the transaction, the executive vice president directly owned 14,849 shares of the company’s stock, valued at approximately $6,533,560. The trade was a 8.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.34% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ELV. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Elevance Health in a research report on Wednesday, November 11th. Mizuho set a $490.00 price target on shares of Elevance Health in a research report on Friday, October 23rd. Wells Fargo & Company boosted their price objective on Elevance Health from $473.00 to $492.00 and gave the company an “overweight” rating in a research report on Tuesday, October 27th. UBS Group upped their target price on shares of Elevance Health from $460.00 to $523.00 and gave the company a “buy” rating in a research note on Thursday, October 22nd. Finally, Barclays raised their target price on Elevance Health from $469.00 to $472.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Sixteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $458.91.

View Our Latest Research Report on ELV

Elevance Health Company Profile

(Free Report)

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

Read More

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).

Institutional Ownership by Quarter for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.